John LaMattina, who is covereing pharma and healthcare for Forbes, writes on the debate over the cost to develop a new drug:
“One of the valuable studies that Tufts CSDD has provided over the years has been an analysis of the costs of bringing a new drug to market. It recently released its latest estimate and it comes in at a whopping $2.56 billion per drug!
“To someone familiar with the long and arduous drug discovery and development process, this number wasn’t too shocking. But for others, the study was immediately called into question, if not scorned … “